These findings support the idea that the observed detrimental effects of obesity in iRhom2-deficient mice could be at least partly due to a failure of iRhom2-dependent activation of ADAM17-mediated signaling events. This evidence concerns the gene RHBDF2 and obesity due to melanocortin 4 receptor deficiency.